David Moatazedi

Track

Insider profile

Currently holds positions in Vyome Holdings Inc and Evolus Inc

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 92% 68% 82%
Transactions
11 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Vyome Holdings Inc March 13, 2017 -
President, Chief Executive Officer, Director Evolus Inc May 6, 2018 -
David Moatazedi's trades of Evolus Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Evolus Inc (EOLS)
Transaction date
Sale
Price
491.85
Quantity 82,581 +46.5%
Value US$3,838,318
US Evolus Inc (EOLS)
Transaction date
Proposed sale
Price
422.25
Quantity 92,249
Value US$3,614,103
US Biomerica Inc (BMRA)
Transaction date
Purchase
Price
249.40
Quantity 47,874 +9.6%
Value US$578,970
US Evolus Inc (EOLS)
Transaction date
Planned sale
Price
4.75
Quantity 13,669 -2.2%
Value US$64,929
US Evolus Inc (EOLS)
Transaction date
Planned sale
Price
4.89
Quantity 116,720 -15.9%
Value US$570,562
US Evolus Inc (EOLS)
Transaction date
Planned sale
Price
7.15
Quantity 10,539 -2.9%
Value US$75,361
US Evolus Inc (EOLS)
Transaction date
Proposed sale
Price
9.89
Quantity 16,582
Value US$164,052
US Evolus Inc (EOLS)
Transaction date
Sale
Price
9.89
Quantity 16,582 -4.3%
Value US$164,054
US Evolus Inc (EOLS)
Transaction date
Sale
Price
10.05
Quantity 111,323 -22.6%
Value US$1,119,141
US Evolus Inc (EOLS)
Transaction date
Proposed sale
Price
10.05
Quantity 111,323
Value US$1,119,141
US Evolus Inc (EOLS)
Transaction date
Planned sale
Price
9.87
Quantity 15,787 -3.1%
Value US$155,756
US Evolus Inc (EOLS)
Transaction date
Planned sale
Price
12.40
Quantity 6,251 -1.2%
Value US$77,512
US Evolus Inc (EOLS)
Transaction date
Planned sale
Price
13.26
Quantity 103,376 -16.7%
Value US$1,370,249
US Evolus Inc (EOLS)
Transaction date
Planned sale
Price
10.85
Quantity 10,502 -2.0%
Value US$113,967
US Evolus Inc (EOLS)
Transaction date
Proposed sale
Price
12.70
Quantity 200,000
Value US$2,540,000
US Evolus Inc (EOLS)
Transaction date
Sale
Price
12.59
Quantity 175,940 -24.8%
Value US$2,214,486
US Evolus Inc (EOLS)
Transaction date
Sale
Price
12.92
Quantity 155,278 -22.5%
Value US$2,006,456
US Evolus Inc (EOLS)
Transaction date
Proposed sale
Price
12.70
Quantity 155,278
Value US$1,972,031
US Evolus Inc (EOLS)
Transaction date
Sale
Price
12.73
Quantity 140,214 -20.8%
Value US$1,784,686
US Evolus Inc (EOLS)
Transaction date
Proposed sale
Price
12.70
Quantity 140,214
Value US$1,780,718
US Evolus Inc (EOLS)
Transaction date
Sale
Price
12.72
Quantity 16,051 -2.3%
Value US$204,127
US Evolus Inc (EOLS)
Transaction date
Sale
Price
13.86
Quantity 6,236 -0.9%
Value US$86,431
US Evolus Inc (EOLS)
Transaction date
Sale
Price
13.92
Quantity 96,566 -12.2%
Value US$1,344,604
US Evolus Inc (EOLS)
Transaction date
Planned sale
Price
13.08
Quantity 7,706 -1.0%
Value US$100,804
US Evolus Inc (EOLS)
Transaction date
Sale
Price
9.73
Quantity 31,300 -4.9%
Value US$304,505
US Evolus Inc (EOLS)
Transaction date
Sale
Price
10.09
Quantity 51,348 -7.5%
Value US$517,891
US Evolus Inc (EOLS)
Transaction date
Proposed sale
Price
10.00
Quantity 82,648
Value US$826,480
US Evolus Inc (EOLS)
Transaction date
Planned sale
Price
10.27
Quantity 14,778 -2.1%
Value US$151,770
US Evolus Inc (EOLS)
Transaction date
Planned sale
Price
8.47
Quantity 6,110 -1.0%
Value US$51,752
US Evolus Inc (EOLS)
Transaction date
Planned sale
Price
8.47
Quantity 64,211 -9.4%
Value US$543,797
US Evolus Inc (EOLS)
Transaction date
Sale
Price
13.64
Quantity 55,321 -10.1%
Value US$754,307
US Evolus Inc (EOLS)
Transaction date
Planned sale
Price
11.62
Quantity 6,104 -1.1%
Value US$70,928
US Evolus Inc (EOLS)
Transaction date
Planned sale
Price
9.73
Quantity 37,972 -6.4%
Value US$369,293
US Evolus Inc (EOLS)
Transaction date
Planned sale
Price
7.46
Quantity 8,310 -4.6%
Value US$61,993
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-04 2026-09-02
US Evolus Inc (EOLS)
S Sale
82,581 +46.5%
491.85
US$3,838,318 		82,581 +46.5% 491.85 US$3,838,318
2026-09-02 2026-09-02
US Evolus Inc (EOLS)
PrS Proposed sale
92,249
422.25
US$3,614,103 		92,249 422.25 US$3,614,103
2026-08-27 2026-08-26
US Biomerica Inc (BMRA)
B Purchase
47,874 +9.6%
249.40
US$578,970 		47,874 +9.6% 249.40 US$578,970
2026-03-20 2026-03-20
US Evolus Inc (EOLS)
PlS Planned sale
13,669 -2.2%
4.75
US$64,929 		13,669 -2.2% 4.75 US$64,929
2026-03-18 2026-03-17
US Evolus Inc (EOLS)
PlS Planned sale
116,720 -15.9%
4.89
US$570,562 		116,720 -15.9% 4.89 US$570,562
2025-12-29 2025-12-22
US Evolus Inc (EOLS)
PlS Planned sale
10,539 -2.9%
7.15
US$75,361 		10,539 -2.9% 7.15 US$75,361
2025-06-16 2025-06-16
US Evolus Inc (EOLS)
PrS Proposed sale
16,582
9.89
US$164,052 		16,582 9.89 US$164,052
2025-06-16 2025-06-16
US Evolus Inc (EOLS)
S Sale
16,582 -4.3%
9.89
US$164,054 		16,582 -4.3% 9.89 US$164,054
2025-06-16 2025-06-13
US Evolus Inc (EOLS)
S Sale
111,323 -22.6%
10.05
US$1,119,141 		111,323 -22.6% 10.05 US$1,119,141
2025-06-13 2025-06-13
US Evolus Inc (EOLS)
PrS Proposed sale
111,323
10.05
US$1,119,141 		111,323 10.05 US$1,119,141
2025-05-14 2025-05-12
US Evolus Inc (EOLS)
PlS Planned sale
15,787 -3.1%
9.87
US$155,756 		15,787 -3.1% 9.87 US$155,756
2025-03-28 2025-03-27
US Evolus Inc (EOLS)
PlS Planned sale
6,251 -1.2%
12.40
US$77,512 		6,251 -1.2% 12.40 US$77,512
2025-03-20 2025-03-18
US Evolus Inc (EOLS)
PlS Planned sale
103,376 -16.7%
13.26
US$1,370,249 		103,376 -16.7% 13.26 US$1,370,249
2024-12-26 2024-12-23
US Evolus Inc (EOLS)
PlS Planned sale
10,502 -2.0%
10.85
US$113,967 		10,502 -2.0% 10.85 US$113,967
2024-06-06 2024-06-06
US Evolus Inc (EOLS)
PrS Proposed sale
200,000
12.70
US$2,540,000 		200,000 12.70 US$2,540,000
2024-06-06 2024-06-06
US Evolus Inc (EOLS)
S Sale
175,940 -24.8%
12.59
US$2,214,486 		175,940 -24.8% 12.59 US$2,214,486
2024-06-06 2024-06-05
US Evolus Inc (EOLS)
S Sale
155,278 -22.5%
12.92
US$2,006,456 		155,278 -22.5% 12.92 US$2,006,456
2024-06-05 2024-06-05
US Evolus Inc (EOLS)
PrS Proposed sale
155,278
12.70
US$1,972,031 		155,278 12.70 US$1,972,031
2024-06-06 2024-06-04
US Evolus Inc (EOLS)
S Sale
140,214 -20.8%
12.73
US$1,784,686 		140,214 -20.8% 12.73 US$1,784,686
2024-06-04 2024-06-04
US Evolus Inc (EOLS)
PrS Proposed sale
140,214
12.70
US$1,780,718 		140,214 12.70 US$1,780,718
2024-05-14 2024-05-10
US Evolus Inc (EOLS)
S Sale
16,051 -2.3%
12.72
US$204,127 		16,051 -2.3% 12.72 US$204,127
2024-03-29 2024-03-27
US Evolus Inc (EOLS)
S Sale
6,236 -0.9%
13.86
US$86,431 		6,236 -0.9% 13.86 US$86,431
2024-03-21 2024-03-19
US Evolus Inc (EOLS)
S Sale
96,566 -12.2%
13.92
US$1,344,604 		96,566 -12.2% 13.92 US$1,344,604
2024-02-23 2024-02-22
US Evolus Inc (EOLS)
PlS Planned sale
7,706 -1.0%
13.08
US$100,804 		7,706 -1.0% 13.08 US$100,804
2023-12-08 2023-12-08
US Evolus Inc (EOLS)
S Sale
31,300 -4.9%
9.73
US$304,505 		31,300 -4.9% 9.73 US$304,505
2023-12-08 2023-12-06
US Evolus Inc (EOLS)
S Sale
51,348 -7.5%
10.09
US$517,891 		51,348 -7.5% 10.09 US$517,891
2023-12-06 2023-12-06
US Evolus Inc (EOLS)
PrS Proposed sale
82,648
10.00
US$826,480 		82,648 10.00 US$826,480
2023-08-16 2023-08-16
US Evolus Inc (EOLS)
PlS Planned sale
14,778 -2.1%
10.27
US$151,770 		14,778 -2.1% 10.27 US$151,770
2023-03-29 2023-03-27
US Evolus Inc (EOLS)
PlS Planned sale
6,110 -1.0%
8.47
US$51,752 		6,110 -1.0% 8.47 US$51,752
2023-03-16 2023-03-14
US Evolus Inc (EOLS)
PlS Planned sale
64,211 -9.4%
8.47
US$543,797 		64,211 -9.4% 8.47 US$543,797
2022-05-18 2022-05-16
US Evolus Inc (EOLS)
S Sale
55,321 -10.1%
13.64
US$754,307 		55,321 -10.1% 13.64 US$754,307
2022-03-30 2022-03-28
US Evolus Inc (EOLS)
PlS Planned sale
6,104 -1.1%
11.62
US$70,928 		6,104 -1.1% 11.62 US$70,928
2022-03-10 2022-03-08
US Evolus Inc (EOLS)
PlS Planned sale
37,972 -6.4%
9.73
US$369,293 		37,972 -6.4% 9.73 US$369,293
2021-01-26 2021-01-25
US Evolus Inc (EOLS)
PlS Planned sale
8,310 -4.6%
7.46
US$61,993 		8,310 -4.6% 7.46 US$61,993